EP 2762155 A2 20140806 - Vaccine Composition
Title (en)
Vaccine Composition
Title (de)
Impfstoffzusammensetzung
Title (fr)
Composition vaccinale
Publication
Application
Priority
JP 2013020734 A 20130205
Abstract (en)
The invention provides a vaccine composition containing an antigen for inducing cellular immunity, comprising at least one first cellular immunity induction promoter.
IPC 8 full level
A61K 39/00 (2006.01)
CPC (source: EP KR US)
A61K 9/0014 (2013.01 - US); A61K 31/192 (2013.01 - EP KR US); A61K 31/196 (2013.01 - EP KR US); A61K 31/216 (2013.01 - EP US); A61K 31/353 (2013.01 - EP US); A61K 31/4035 (2013.01 - EP US); A61K 31/405 (2013.01 - EP US); A61K 31/407 (2013.01 - EP KR US); A61K 31/415 (2013.01 - EP US); A61K 31/42 (2013.01 - EP US); A61K 31/426 (2013.01 - EP US); A61K 31/5575 (2013.01 - EP US); A61K 31/616 (2013.01 - EP KR US); A61K 38/08 (2013.01 - KR); A61K 38/10 (2013.01 - EP KR US); A61K 39/00 (2013.01 - EP US); A61K 39/0011 (2013.01 - EP KR US); A61K 39/39 (2013.01 - US); A61K 45/06 (2013.01 - KR); A61P 31/00 (2018.01 - EP); A61P 35/00 (2018.01 - EP); A61P 35/04 (2018.01 - KR); A61P 37/00 (2018.01 - EP); A61P 37/04 (2018.01 - EP KR); A61K 2039/54 (2013.01 - EP KR US); A61K 2039/541 (2013.01 - KR); A61K 2039/572 (2013.01 - EP KR US); A61K 2121/00 (2013.01 - KR)
Citation (applicant)
- US 2008193487 A1 20080814 - SCHILD HANSJOERG [DE], et al
- JP 2002531415 A 20020924
- US 2008112974 A1 20080515 - CZERKINSKY CECIL [FR], et al
- JP H07505883 A 19950629
- JP 2007529531 A 20071025
- JP 4422903 B2 20100303
- WO 0006602 A1 20000210 - SUGIYAMA HARUO [JP], et al
- WO 2005095598 A1 20051013 - SUGIYAMA HARUO [JP]
- WO 2007097358 A1 20070830 - UNIV OSAKA [JP], et al
- WO 2008081701 A1 20080710 - INT INST CANCER IMMUNOLOGY INC [JP], et al
- WO 9850399 A1 19981112 - RIBI IMMUNOCHEM RESEARCH INC [US]
- US 6303347 B1 20011016 - JOHNSON DAVID A [US], et al
- US 6764840 B2 20040720 - JOHNSON DAVID A [US], et al
- HOSOI AKIHIRO ET AL., CANCER RESEARCH, vol. 68, 2008, pages 3941 - 3949
- ZHENGRONG CUI ET AL., PHARMACEUTICAL RESEARCH, vol. 19, no. 7, 2002, pages 947 - 953
- PM ROTHWELL ET AL., THE LANCET, vol. 376, no. 9754, 2010, pages 1741 - 1750
- K JOLLY ET AL., DRUGS, vol. 62, no. 6, 2002, pages 945 - 956
- A AGRAWAL., INT J CLIN PRACT, vol. 62, no. 3, 2008, pages 444 - 449
- KAWAI ET AL., NUCLEIC ACIDS RESEARCH, vol. 3, pages 103 - 4
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
EP 2762155 A2 20140806; EP 2762155 A3 20151104; EP 2762155 B1 20200311; CA 2840959 A1 20140805; CN 103961701 A 20140806; CN 103961701 B 20180914; EP 3662927 A2 20200610; EP 3662927 A3 20201021; IN 396CH2014 A 20150403; JP 2014169281 A 20140918; JP 6473292 B2 20190220; KR 20140100422 A 20140814; RU 2014102945 A 20150810; US 10076491 B2 20180918; US 2014220063 A1 20140807
DOCDB simple family (application)
EP 14000320 A 20140129; CA 2840959 A 20140129; CN 201410043652 A 20140129; EP 19217427 A 20140129; IN 396CH2014 A 20140129; JP 2014014809 A 20140129; KR 20140011639 A 20140129; RU 2014102945 A 20140129; US 201414166965 A 20140129